An effective gene-knockdown using multiple shRNA-expressing adenovirus vectors

Viral vectors expressing short hairpin RNA (shRNA) are attractive for efficient and tissue-specific RNA interference (RNAi) delivery. We and others previously reported that recombinant adenovirus (Ad) vector-mediated RNAi has great potential for a variety of applications in molecular biology studies...

Full description

Saved in:
Bibliographic Details
Published in:Journal of controlled release 2011-07, Vol.153 (2), p.149-153
Main Authors: Motegi, Yukari, Katayama, Kazufumi, Sakurai, Fuminori, Kato, Takuya, Yamaguchi, Tomoko, Matsui, Hayato, Takahashi, Masahide, Kawabata, Kenji, Mizuguchi, Hiroyuki
Format: Article
Language:English
Subjects:
Adenoviridae - genetics
Adenovirus
Adenovirus vector
Biological and medical sciences
cisplatin
cytotoxicity
DNA-Binding Proteins - genetics
Gene Knockdown Techniques - methods
Gene therapy
General pharmacology
genetic vectors
Genetic Vectors - genetics
HeLa Cells
Humans
Medical sciences
molecular biology
Nuclear Proteins - genetics
oncogenes
oxidative stress
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
RNA Interference
RNA, Small Interfering - genetics
RNAi
small interfering RNA
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Viral vectors expressing short hairpin RNA (shRNA) are attractive for efficient and tissue-specific RNA interference (RNAi) delivery. We and others previously reported that recombinant adenovirus (Ad) vector-mediated RNAi has great potential for a variety of applications in molecular biology studies and gene therapy. In the present study, we have developed an efficient Ad vector-mediated RNAi system, in which an Ad vector carries four shRNA-expression cassettes (Ad-multi-shRNA vector), a simple and effective strategy for enhancing the RNAi response per Ad vector particle. The data demonstrated that the Ad-multi-shRNA vectors showed an enhanced RNAi effect compared to conventional Ad vectors containing a single shRNA-expression cassette. An application of the Ad-multi-shRNA vector carrying four same shRNA-sequences against the RET finger protein, an oncogene known to desensitize cells to oxidative stress and cisplatin, resulted in an enhanced cytotoxic effect of cisplatin, demonstrating the advantages of the Ad-multi-shRNA vector for silencing target genes. Furthermore, an Ad-multi-shRNA carrying four different shRNA-sequences efficiently silenced the multiple target genes simultaneously. These data suggest the potential usefulness of the Ad-multi-shRNA vector not only in basic research but also in clinical gene therapy. [Display omitted]
ISSN:0168-3659
1873-4995
DOI:10.1016/j.jconrel.2011.04.009